Sofinnova Investments, Inc. Aerovate Therapeutics, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.36 Billion
- Q1 2025
A detailed history of Sofinnova Investments, Inc. transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 3,758,686 shares of AVTE stock, worth $10.1 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
3,758,686
Previous 3,758,686
-0.0%
Holding current value
$10.1 Million
Previous $9.96 Million
5.28%
% of portfolio
0.69%
Previous 0.81%
Shares
1 transactions
Others Institutions Holding AVTE
# of Institutions
85Shares Held
32.3MCall Options Held
30.3KPut Options Held
57.9K-
Ra Capital Management, L.P. Boston, MA9.19MShares$24.6 Million0.48% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA2.24MShares$6.01 Million1.35% of portfolio
-
Atlas Venture Life Science Advisors, LLC1.8MShares$4.82 Million1.32% of portfolio
-
Adar1 Capital Management, LLC Austin, TX1.46MShares$3.92 Million0.68% of portfolio
-
Braidwell LP Stamford, CT1.44MShares$3.86 Million0.22% of portfolio
About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $65.5M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...